BioShield Develops New Solid Form Antimicrobial - BST 1870 To Be Marketed in the $2 Trillion Worldwide Healthcare Sector
BST 1870 Developed to Become FDA Grade Product
21-Jun-2002
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Clinical Trials Initiated and Significant Milestone Reached in the Collaboration Between Karo Bio and Merck & Co., Inc.
Go to page
Lee's Pharmaceutical Holdings Ltd - Hong Kong, Hong Kong
Go to page
Giving transplanted cells a nanotech checkup - Researchers devise way to safely see whether replacement cells are still alive
Go to page
Pharmacia and Paladin Enter Into Distribution Agreement for Certain Endocrinology and Women's Health Brands
Go to page
Novartis and Alnylam Create Major Alliance to Discover RNAi Therapeutics
Go to page
ThromboGenics and BioInvent Awarded Euro 2 Million EU Grant for ANGIOSTOP Anti-Angiogenesis Programme
Go to page
Cancer genes hijack enhancers
Go to page
DOYMA GmbH & CO - Oyten, Germany
Go to page
AstraZeneca Pharmaceuticals LP Selects Ariba Enterprise Sourcing
Go to page
LEONHARD WEISS GmbH & Co. KG - Satteldorf, Germany
Go to page
Radiation_therapy
Go to page
Synvolux Therapeutics B.V. - Groningen, Netherlands
Go to page